These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8339416)

  • 1. A simplified, single-lead unipolar transvenous cardioversion-defibrillation system.
    Bardy GH; Johnson G; Poole JE; Dolack GL; Kudenchuk PJ; Kelso D; Mitchell R; Mehra R; Hofer B
    Circulation; 1993 Aug; 88(2):543-7. PubMed ID: 8339416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective randomized comparison of biphasic waveform tilt using a unipolar defibrillation system.
    Poole JE; Bardy GH; Kudenchuk PJ; Dolack GL; Raitt MH; Mehra R; Johnson G
    Pacing Clin Electrophysiol; 1995 Jul; 18(7):1369-73. PubMed ID: 7567589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective, randomized comparison in humans of a unipolar defibrillation system with that using an additional superior vena cava electrode.
    Bardy GH; Dolack GL; Kudenchuk PJ; Poole JE; Mehra R; Johnson G
    Circulation; 1994 Mar; 89(3):1090-3. PubMed ID: 8124794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized comparison in humans of biphasic waveform 60-microF and 120-microF capacitance pulses using a unipolar defibrillation system.
    Bardy GH; Poole JE; Kudenchuk PJ; Dolack GL; Mehra R; DeGroot P; Raitt MH; Jones GK; Johnson G
    Circulation; 1995 Jan; 91(1):91-5. PubMed ID: 7805224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a single-lead unipolar transvenous defibrillator compared with a system employing an additional coronary sinus electrode. A prospective, randomized study.
    Kudenchuk PJ; Bardy GH; Dolack GL; Poole JE; Mehra R; Johnson G
    Circulation; 1994 Jun; 89(6):2641-4. PubMed ID: 8205676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A permanent transvenous lead system for an implantable pacemaker cardioverter-defibrillator. Nonthoracotomy approach to implantation.
    Yee R; Klein GJ; Leitch JW; Guiraudon GM; Guiraudon CM; Jones DL; Norris C
    Circulation; 1992 Jan; 85(1):196-204. PubMed ID: 1728450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lead system optimization for transvenous defibrillation.
    Gold MR; Foster AH; Shorofsky SR
    Am J Cardiol; 1997 Nov; 80(9):1163-7. PubMed ID: 9359543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantation of a unipolar cardioverter/defibrillator system under local anaesthesia.
    Stix G; Anvari A; Grabenwöger M; Merhaut C; Türel Z; Laufer G; Schmidinger H
    Eur Heart J; 1996 May; 17(5):764-8. PubMed ID: 8737108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S; Tullo NG; Krol RB; Mauro AM
    Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transvenous biventricular defibrillation.
    Meisel E; Butter C; Philippon F; Higgins S; Strickberger SA; Smith J; Hahn S; Michel U; Schubert B; Pfeiffer D
    Am J Cardiol; 2000 Nov; 86(9A):76K-85K. PubMed ID: 11084104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of epicardial patches on defibrillation threshold with nonthoracotomy lead configurations.
    Fotuhi PC; Ideker RE; Idriss SF; Callihan RL; Walker RG; Alt EU
    Circulation; 1995 Nov; 92(10):3082-8. PubMed ID: 7586279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, randomized, comparison in patients between a pectoral unipolar defibrillation system and that using an additional inferior vena cava electrode.
    Favale S; Dicandia CD; Tunzi P; Rizzon P
    Pacing Clin Electrophysiol; 1999 Aug; 22(8):1140-5. PubMed ID: 10461288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a single element subcutaneous array electrode added to a transvenous electrode configuration on the defibrillation field and the defibrillation threshold.
    Kühlkamp V; Dörnberger V; Khalighi K; Mewis C; Suchalla R; Ziemer G; Seipel L
    Pacing Clin Electrophysiol; 1998 Dec; 21(12):2596-605. PubMed ID: 9894650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of defibrillator-can size on defibrillation success with a single-lead unipolar system.
    Newby KH; Moredock L; Rembert J; Wharton JM; Natale A
    Am Heart J; 1996 Feb; 131(2):261-5. PubMed ID: 8579018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Truncated biphasic pulses for transthoracic defibrillation.
    Bardy GH; Gliner BE; Kudenchuk PJ; Poole JE; Dolack GL; Jones GK; Anderson J; Troutman C; Johnson G
    Circulation; 1995 Mar; 91(6):1768-74. PubMed ID: 7882486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical predictors of the defibrillation threshold with the unipolar implantable defibrillation system.
    Raitt MH; Johnson G; Dolack GL; Poole JE; Kudenchuk PJ; Bardy GH
    J Am Coll Cardiol; 1995 Jun; 25(7):1576-83. PubMed ID: 7759708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentre comparison Of shock efficacy using single-vs. Dual-coil lead systems and Anodal vs. cathodaL polarITY defibrillation in patients undergoing transvenous cardioverter-defibrillator implantation. The MODALITY study.
    Baccillieri MS; Gasparini G; Benacchio L; Zorzi A; Marras E; Zerbo F; Tomasi L; Vaccari D; Pastore G; Bonanno C; Molon G; Zanotto G; Fusco A; Carasi M; Zorzi A; Calzolari V; Ignatiuk B; Cannas S; Vaglio A; Al Bunni M; Pedrini A; Olivieri A; Rampazzo R; Minicuci N; Corrado D; Verlato R
    J Interv Card Electrophysiol; 2015 Jun; 43(1):45-54. PubMed ID: 25690336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of shock polarity on ventricular defibrillation threshold using a transvenous lead system.
    Strickberger SA; Hummel JD; Horwood LE; Jentzer J; Daoud E; Niebauer M; Bakr O; Man KC; Williamson BD; Kou W
    J Am Coll Cardiol; 1994 Oct; 24(4):1069-72. PubMed ID: 7930199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators.
    Swerdlow CD; Ahern T; Kass RM; Davie S; Mandel WJ; Chen PS
    J Am Coll Cardiol; 1996 Apr; 27(5):1112-8. PubMed ID: 8609329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated defibrillation threshold when right-sided venous access is used for nonthoracotomy implantable defibrillator lead implantation. The Endotak Investigators.
    Epstein AE; Kay GN; Plumb VJ; Voshage-Stahl L; Hull ML
    J Cardiovasc Electrophysiol; 1995 Nov; 6(11):979-86. PubMed ID: 8589875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.